Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
Roche's Gazyva succeeds in key lupus nephritis trial
Roche has shown results of a phase 3 trial which set up Gazyva for potential approval in what would be its most important indication—lupus nephritis.
Kevin Dunleavy
Feb 7, 2025 11:14am
FDA gives thumbs-up to Roche's Susvimo as treatment for DME
Feb 4, 2025 3:15pm
Merck, Pfizer among pharmas commemorating World Cancer Day 2025
Feb 4, 2025 11:52am
UK watchdog reaffirms Bayer's claims of misleading Roche promos
Jan 31, 2025 11:20am
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Jan 30, 2025 11:06am
Roche's Itovebi pads its case with overall survival win
Jan 28, 2025 4:00pm